Skip to main content

Peer Review reports

From: Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic cancer

Original Submission
25 Nov 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
16 Dec 2022 Reviewed Reviewer Report
5 Jan 2023 Reviewed Reviewer Report
29 Jan 2023 Author responded Author comments - Shanyu Qin
Resubmission - Version 4
29 Jan 2023 Submitted Manuscript version 4
8 Feb 2023 Author responded Author comments - Shanyu Qin
Resubmission - Version 5
8 Feb 2023 Submitted Manuscript version 5
9 Feb 2023 Author responded Author comments - Shanyu Qin
Resubmission - Version 6
9 Feb 2023 Submitted Manuscript version 6
14 Mar 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
17 Mar 2023 Editorially accepted
22 Mar 2023 Article published 10.1186/s12885-023-10749-x

You can find further information about peer review here.

Back to article page